IN RE ZOLOFT PRODUCTS LIABILITY LITIGATION

MDL NO. 2342, 12-MD-2342.

176 F.Supp.3d 483 (2016)

IN RE: ZOLOFT (SERTRALINEHYDROCHLORIDE) PRODUCTS LIABILITY LITIGATION. This Document Relates to: All Actions.

United States District Court, E.D. Pennsylvania.

Signed April 5, 2016.


Attorney(s) appearing for the Case

Sheila L. Birnbaum , Mark S. Cheffo , Bert L. Wolff , Jonathan S. Tam , Quinn Emanuel Urquhart & Sullivan, LLP, Pamela J. Yates , Bert L. Slonim , Aaron H. Levine , Kaye Scholer, LLP, New York, NY, James E. Hooper, Jr. , Andrew H. Myers , Wheeler Trigg O'Donnell LLP, Denver, CO, Robert C. Heim , Judy L. Leone , Dechert, LLP, Philadelphia, PA, for Pfizer.


OPINION

By Order filed April 17, 2012, the United States Judicial Panel on MultiDistrict Litigation transferred to this Court, for coordinated or consolidated pretrial proceedings, cases alleging that Zoloft (sertraline hydrochloride), "a prescription medication approved for the treatment of depression and other ailments, causes...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases